Novel nonsecosteroidal vitamin D receptor modulator inhibits the growth of LNCaP xenograft tumors in athymic mice without increased serum calcium

Prostate

Volumn 49, Issue 3, 2001, Pages 224-233

  Polek, Tara C ^a   Murthy, Shalini ^a   Blutt, Sarah E ^a   Boehm, Marcus F ^b   Zou, Aihua ^b   Weigel, Nancy L ^a   Allegretto, Elizabeth A ^b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b LIGAND PHARMACEUTICALS INC   (United States)

^c DUPONT COMPANY   (United States)

Author keywords

LNCaP tumors; Nonsecosteroid; Prostate cancer; Vitamin D mimic; Vitamin D receptor

Indexed keywords

ANTINEOPLASTIC AGENT; CALCITRIOL; CALCIUM; LG 190119; SECOSTEROID; SEOCALCITOL; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CALCIUM BLOOD LEVEL; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; DRUG STRUCTURE; HUMAN; MODULATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; BIPHENYL COMPOUNDS; BODY WEIGHT; CALCIUM; CELL DIVISION; GROWTH INHIBITORS; HUMANS; KETONES; MALE; MICE; MICE, NUDE; PROSTATIC NEOPLASMS; RANDOM ALLOCATION; RECEPTORS, CALCITRIOL; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035157533     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.1138     Document Type: Article

References (50)

1. Basic and clinical concepts related to vitamin D metabolism and action
2. The vitamin D story: A collaborative effort of basic science and clinical medicine
3. 3
4. 3
5. 3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): Receptormediated maturation to macrophage-like cells
6. Possible role for vitamin D in controlling breast cancer cell proliferation
7. 3 and tamoxifen on the growth of MCF-7 and ZR-75-1 human breast cancer cells
8. Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line
9. 3 receptors and actions in human prostate cancer cell lines
10. Human prostate cancer cells: Inhibition of proliferation by vitamin D analogs
11. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines
12. Is vitamin D deficiency a risk factor for prostate cancer?
13. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation
14. Vitamin D and prostate cancer: A prediagnostic study with stored sera
15. Prostate cancer risk and prediagnostic serum 25-hydroxy-vitamin D levels (Finland)
16. Action of 1,25-(OH)2D3 in nude mice bearing transplantable human myelogenous leukemic cell lines
17. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro
18. 3
19. 3 in chemically induced rat colon carcinogenesis
20. Structure-function relationships in the vitamin D endocrine system
21. Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study
22. Topical calcipotriol treatment in advanced breast cancer
23. Tamoxifen in the treatment of breast cancer
24. Raloxifene: A new choice for treating and preventing osteoporosis
25. 3
26. 3 and prostate cancer cell proliferation in vivo
27. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system
28. Inhibition of prostate cancer metastasis in vivo: A comparison of 1,25-dihydroxyvitamin D (calcitriol) and EB1089
29. 3
30. 1
31. EB1089: A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro
32. 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/1 mice
33. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis
34. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis
35. The potential of vitamin D analogs for the treatment of Alzheimer's disease
36. Flutamide: An antiandrogen for advanced prostate cancer
37. Transplantation of human prostatic carcinoma into nude mice in matrigel
38. Studies on the human prostatic cancer cell line LNCaP
39. p53 oncogene mutations in three human prostate cancer cell lines
40. Androgen receptor gene expression in human prostate carcinoma cell lines
41. PAP and PSA in prostatic carcinoma cell lines and aspiration biopsies: Relation to hormone sensitivity and to cytological grading
42. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene
43. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo
44. Evidence for the uptake of a vitamin D analogue (OCT) by a human carcinoma and its effect of suppressing the transcription of parathyroid hormone-related peptide gene in vivo
45. Reversal of hypercalcemia with the vitamin D analogue EB1089 in a human model of squamous cancer
46. From ligand to response: Generating diversity in nuclear receptor coregulator function
47. Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta
48. Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog
49. Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate
50. A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice